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Abstract
 Multiple sclerosis has an extremely variable natural course. InBackground:
most patients, disease starts with a relapsing-remitting (RR) phase, which
proceeds to a secondary progressive (SP) form. The duration of the RR phase
is hard to predict, and to date predictions on the rate of disease progression
remain suboptimal. This limits the opportunity to tailor therapy on an individual
patient's prognosis, in spite of the choice of several therapeutic options.
Approaches to improve clinical decisions, such as collective intelligence of
human groups and machine learning algorithms are widely investigated.
 Medical students and a machine learning algorithm predicted theMethods:
course of disease on the basis of randomly chosen clinical records of patients
that attended at the Multiple Sclerosis service of Sant'Andrea hospital in Rome.
 A significant improvement of predictive ability was obtained whenResults:
predictions were combined with a weight that depends on the consistence of
human (or algorithm) forecasts on a given clinical record.
 In this work we present proof-of-principle that human-machineConclusions:
hybrid predictions yield better prognoses than machine learning algorithms or
groups of humans alone. To strengthen this preliminary result, we propose a
crowdsourcing initiative to collect prognoses by physicians on an expanded set
of patients.
Keywords
Multiple sclerosis, Machine learning, Random Forest, collective intelligence,
Hybrid predictions, Crowdsourcing
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Introduction
The natural course of multiple sclerosis (MS) is extremely 
variable, ranging from extremely mild to very aggressive 
forms. Most patients experience an initial relapsing-remitting 
(RR) phase, in which symptoms appear and fade. Eventually, 
remissions fail and the disease proceeds to a secondary progres-
sive (SP) form, leading to incremental disability. The palette of 
disease-modifying treatments is becoming relatively large, in 
principle opening the possibility to tailor the therapy to meet 
the specific needs of each patient. Unfortunately, the accuracy 
of parameters to predict the rate of disease progression remains 
suboptimal.
Being all the above therapies preventive, in the absence of 
exact prognostic indicators we have to accept that a propor-
tion of patients is either under- or over-treated. This is a serious 
concern as the disease can be severely disabling, and some of the 
available therapies can lead to adverse events that can be worse 
than the disease itself. Thus, the possibility to formulate a prog-
nosis as exact as possible is becoming increasingly appealing.
In the clinics, as in any other fields of human knowledge, 
innovative approaches based on machine learning and collec-
tive reasoning methods are used in an attempt to succeed where 
traditional methods of forecasting failed. Machine learning 
algorithms catch complex relations among existing data to an 
extent beyond standard regression models. Good performances 
have been obtained for the diagnosis of Parkinson’s disease and 
the prognosis of disease progression in amyotrophic lateral scle-
rosis (Dinov et al., 2016; Küffner et al., 2015). For MS, machine 
learning algorithms can correctly classify disease course in about 
70 % of cases of both clinically definite MS and of clinically 
isolated syndrome (Fiorini et al., 2015; ; 
Zhao et al., 2017), a good result that still requires improvement 
to become of clinical value. Through collective reasoning, or 
collective intelligence, groups of lay people may perform as well 
as experts. In principle, the larger the group, the higher the predic-
tion accuracy (see for review Ponsonby & Mattingly, 2015), which 
led to the development of several crowdsourcing initiatives for 
diagnostic purposes (for instance, Candido dos Reis et al., 2015; 
Lau et al., 2016). However, when expert people are involved, 
even small groups can outperform the best among them, at least 
when a yes/no answer to well-defined diagnostic questions is 
requested based on radiographic/ histological images, (Kurvers 
et al., 2016; Sonabend et al., 2017; Wolf et al., 2015). Studies 
with medical students show that working in pairs ameliorates 
diagnostic ability, with further improvements when group size 
increases (Hautz et al., 2015; Kämmer et al., 2017), in line with 
the core idea of Collective intelligence.
Combination of human and machine predictions into hybrid 
forecasts exploits human intuitive reasoning and computer 
classification capabilities, potentially boosting both. Indeed, at 
least in the case of predicting the course of actions in American 
football games within the frame of prediction markets, hybrid 
groups performed better than either humans or computers. (Nagar 
& Malone, 2011). In this paper, we report the promising results 
of a preliminary study on the combination of predictions made 
by humans with those of a machine learning algorithm on the 
progression of multiple sclerosis in a set of patients. Machine 
learning and collective intelligence performed almost equally 
well, but their combination yielded a small, yet statistically 
significant, improvement in the reliability of the forecasts on 
disease evolution over different time periods.
These results indicate that it is worth deepening the study of 
human and machine clinical predictions, as well as the potenti-
ality of hybrid predictions, for which we propose a crowdsourc-
ing approach on a platform specifically designed for this analysis 
(DiagnoShare).
Methods and results
Dataset structure
Our dataset is composed by clinical records gathered during 
527 visits of 84 outpatients followed at the Multiple Sclerosis 
service of Sant’Andrea hospital in Rome. Parameters evaluated 
during each visit are listed in Supplementary Table 1. All patients 
had clinically definite MS in the RR stage at the time of the 
visit(s) included in the database. Data potentially revealing the 
identity of the patients was removed from the shared database. 
For each visit, we noted if the patient was in RR or SP stage 
after 180, 360 and 720 days, so that predictions could be 
compared with the true progression of disease in each patient 
(Supplementary File: TrueOutcomes.xlsx).
Ethics
Use of database for research purposes was authorized by the 
Ethical committee of Sapienza University (Authorization n. 4254_
2016, dated November 2, 2016).
Classification with machine learning
Having a correctly labelled dataset, in which each entry is 
associated to the outcome, we used the Random forest super-
vised approach to classification (Breiman, 2001; Liaw & Weiner, 
2002), using the Scikit-learn toolbox version 0.16.1.
To benchmark the performance of the trained models, we used 
a modified k-folding strategy. Since data was limited (a set of 
527 records), and not independent, as it had been obtained from 
84 patients, with a simple random k-folding the training set would 
be composed of many correlated same-patient data. Even worse, 
some of the data from patients present in the training set would 
be used to validate the model in the benchmarking stage. As a 
consequence, the model would overfit the training data, mislead-
ingly showing very good performance. Being presented with many 
data from the same patient, the model optimizes its ability in 
recognizing patients themselves, through their highly correlated 
clinical variables.
To avoid these problems, we developed an alternative approach, 
training the algorithm with the following rules: 
1.  We excluded all visits from one patient from the dataset
2.  We built 50 training sets, each composed by 83 records,
one (randomly chosen) for every remaining patient
3.  We trained 50 Random Forest models, one for each
training set.
Wottschel et al., 2014
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4.    We computed the probability of the transition from RR to 
SP by averaging the predictions of the 50 models on all 
the visits of the excluded patient. Predictions consisted in 
scores from 0 (Extremely unlikely) to 1 (Highly probable).
We repeated the procedure for the 84 patients, obtaining an 
estimation of the probability of the RR to SP transition for each 
of the 527 clinical records. Three different prediction delays were 
considered, namely 180, 360 and 720 days. Results obtained are 
presented in Supplementary File: RF_Predictions.xlsx. The 
performance of the model was estimated by the Area Under 
the “Receiver Operating Characteristic” (ROC) Curve (AUC) 
computed on all the 527 examples. The AUC values obtained are 
shown in Table 1.
Human predictions
Forty-two medical students in the final two years of their course 
(Sapienza University, Rome Italy, based within Sant’Andrea 
hospital), volunteered to participate in the task. All were familiar 
with clinical records in general, and were instructed on the mean-
ing of each entry present in the medical records of MS patients. 
This part of the study was approved by the Ethical Committee 
of the Department of Physiology and Pharmacology, Sapienza 
University on July 13, 2017.
For adequate comparison with computer predictions, students 
evaluated 50 medical records, collected in a questionnaire, 
randomly extracted from the same dataset used for machine 
learning and estimated the probability that the patient would 
progress to the SP phase within 180, 360 and 720 days. Scores 
were from 0 (Extremely unlikely) to 5 (Highly probable). 
Predictions (see Supplementary file Student_Predictions.xlsx) 
were analysed, using the AUC.
On average, each clinical record was evaluated by 4 of the 
42 students.
Predictions were less accurate than those proposed by machine 
learning (Table 1). Standard deviation was larger for the 180 day 
time point, indicating that opinions on the long-term evolution of 
the disease are more widely shared, although they are not more 
precise. To evaluate the impact of collective intelligence, we 
measured the performance of Pairs, considering all visits 
evaluated by at least two individual students, randomly select-
ing only 2 scores when more were available. The prognoses were 
averaged before computing the AUC, which showed a marked 
increase (Table 1). Aggregation of all singles (Group) yielded 
a further small increase in the performance of the forecasting 
(Table 1), which almost equalled that of random forest algorithm.
Hybrid predictions
We next integrated human and computer predictions into a 
hybrid prediction, which combines human clinical reasoning with 
the classification approach of machine learning algorithms. These 
different “ways of reasoning” possibly lead to quite divergent 
predictions on individual cases, a complementarity that should 
be exploited taking the difference into account when creating 
hybrid predictions.
To compare the two sets on equal grounds, predictions on each 
clinical record were ranked in order of consistence, for the two 
agents separately, that is agreement between students or decision 
trees in the random forest. Then, a normalized ranking was 
assigned, ranging from 1 for the most consistent predictions 
to 0 for the most scattered. The hybrid prediction score for each 
clinical record was then obtained by summing the two squared rank-
ings, to emphasize the contribution of the most consistent agent.
Note that a linear combination of rankings would result in a 
worse performance of hybrid predictions, as the information about 
the most consistent prediction between the two agents would 
be lost. A similarly degraded performance is observed when 
predictions are not ranked.
Since our dataset is relatively small, as is the number of students 
that evaluated the clinical records, we used a bootstrap proce-
dure to evaluate the statistical significance of the improvement. 
The bootstrap (Efron & Tibshirani, 1994; Felsenstein, 1985) 
consists in random sampling of the dataset that allows the 
estimation of confidence intervals.
As shown in Table 1 and Figure 1, hybrid predictions yielded a 
small but statistically significant (P<0.001) improvement in the 
prediction of disease course in time. Significance was evaluated 
from confidence limits using standard methods (Altman & Bland, 
2011).
Table 1. Predictions on disease course by different 
agents.
Agent 180 days 360 days 720 days
Random Forest 0.710 0.670 0.679
Singles (n=42) 0.57 ± 0.15 0.57 ± 0.11 0.57 ± 0.10
Pairs 0.68 0.65 0.65
Group 0.703 0.667 0.666
Hybrid predictions 0.725* 0.694* 0.696*
For each clinical record, the indicated agents evaluated the 
probability that disease evolved from the RR to the SP phase after 
180, 360 or 720 days. Data represent the AUC values obtained for 
each method. *: P<0.001 when compared to Group or Random 
Forest values at the same time points.
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Dataset 1. True outcome of patients, indexed as clinical records
http://dx.doi.org/10.5256/f1000research.13114.d188355
More than one clinical record is pertinent to each patient. T_180, 
T_360, T_720: clinical conditions of the patient 180, 360 and 720 
days after the visit in which clinical record was obtained. 0: still in 
RR phase; 1: transitioned to SP phase.
Dataset 2. Predictions on individual clinical records made by 
medical students
http://dx.doi.org/10.5256/f1000research.13114.d188356
Each student worked on a questionnaire (lines labelled 
“questionnaire”, column B.) listing 50 clinical reports (lines labelled 
“Clinical report N”, columns B to AY) and made a prediction on the 
probability of RR –to–SP transition within 180, 360 and 720 days 
(lines labelled Prediction @ 180, 360, 720, columns B to AY)
The numbering of Clinical reports is the same used in Dataset 1.
Dataset 3. Predictions on individual clinical records made by a 
Random Forest algorithm
http://dx.doi.org/10.5256/f1000research.13114.d188357
Score_180, Score_360, Score_720: Probability that the patient will 
transition to SP phase within180, 360 and 720 days after the visit 
in which clinical record was obtained. The numbering of Clinical 
reports is the same used in Dataset 1.
Discussion
A number of studies have investigated the possibility to increase 
the appropriateness of clinical decisions through collective intel-
ligence of human groups (for instance, Kurvers et al., 2016; 
Sonabend et al., 2017; Wolf et al., 2015) or machine learning 
algorithms. The latter approach has been used in a great variety 
of tasks, and its value in the medical realm is possibly overstated 
(Chen & Asch, 2017). However, machine learning methods 
performed well for prognostic predictions (Küffner et al., 2015; 
Zhao et al., 2017). In particular, the Random forest approach 
provided good predictions on ALS course (Küffner et al., 2015).
In this work we present proof-of-principle that human-machine 
hybrid predictions attain prognostic ability above that of machine 
learning algorithms and groups of humans alone.
The duration of the RR phase before its shift into progression 
has always been difficult to predict, and possibly the random 
occurrence of relapses (Bordi et al., 2013) contributes to the lack 
of univocal indicators. No approach, no matter how good, can yield 
certainty when cause-effect relations are unknown. Thus, our aim 
has been to obtain predictions on the probability that MS patients 
in the RR phase will convert to a SP form within a certain time 
frame. Predictions on the course of real patients were provided 
by medical students and a random forest algorithm. A significant 
improvement of predictive ability was obtained when predic-
tions were combined in a non-linear manner, with a weight that 
depends on the consistence of human (or algorithm) forecasts 
on a given clinical record.
This result can be considered in agreement with several studies 
on different medical issues showing that predictor’s confidence 
correlates very well with the correctness of the prediction (Detsky 
et al., 2017; Hautz et al., 2015; Kämmer et al., 2017; Kurvers 
et al., 2016). Indeed, the concordance of different members 
of a given group (students or runs of the random forest model) 
can be taken as indicating that the agent is “sure” of the forecast.
In spite of the relatively basic machine learning technique 
used, the small number of students involved and their limited 
clinical knowledge, this work suggests that hybrid predictions 
can be useful to improve the prognosis of MS course. A deeper 
study is therefore of interest. To recruit more and more 
skilled humans, we propose a crowdsourcing initiative called 
DiagnoShare that is being advertised among physicians.
Figure 1. Hybrid Students – Machine Learning predictions outperform both human group and computer alone. The box plot shows 
the distribution of the AUC obtained from the bootstrap. In particular, the colored boxes correspond to quartiles, while the lines show the full 
range of the generated AUCs.
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A reliable tool to predict MS progression can be of aid to 
clinicians to tailor therapy to each patient, but also in clinical 
trials, to evaluate whether drugs modify the estimated outcome 
of each enrolled patient, as proposed for ALS (Küffner et al., 
2015).
In the long run, it is possible that further developments in our 
ability to combine collective reasoning and machine predic-
tions will have a profound impact also on the organization and 
management of medical care, particularly in hospital settings.
Data availability
Dataset 1: True outcome of patients, indexed as clinical records. 
More than one clinical record is pertinent to each patient. T_180, 
T_360, T_720: clinical conditions of the patient 180, 360 and 
720 days after the visit in which clinical record was obtained. 
0: still in RR phase; 1: transitioned to SP phase. DOI: 10.5256/
f1000research.13114.d188355 (Tacchella et al., 2017a)
Dataset 2: Predictions on individual clinical records made by 
medical students. Each student worked on a questionnaire (lines 
labelled “questionnaire”, column B.) listing 50 clinical reports 
(lines labelled “Clinical report N”, columns B to AY) and made 
a prediction on the probability of RR –to–SP transition within 
180, 360 and 720 days (lines labelled Prediction @ 180, 360, 720, 
columns B to AY)
The numbering of Clinical reports is the same used in Dataset 1. 
DOI: 10.5256/f1000research.13114.d188356 (Tacchella et al., 
2017b)
Dataset 3: Predictions on individual clinical records made by a 
Random Forest algorithm. Score_180, Score_360, Score_720: 
Probability that the patient will transition to SP phase within180, 
360 and 720 days after the visit in which clinical record was 
obtained. The numbering of Clinical reports is the same used in 
Dataset 1. DOI: 10.5256/f1000research.13114.d188357 (Tacchella 
et al., 2017c)
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General:
I think exploring how to fuse multiple expert opinions is a very interesting line of research in computer
aided diagnostics. Here, the authors test how to make use of lay persons, and I would agree that there are
many tasks when a (briefly trained) lay person or non-expert can contribute significantly to an analytical
task.
In the application here, I would be rather critical about this approach, though. For example, the authors
write "through collective reasoning, or collective intelligence, groups of lay people may perform as well as
experts." I would not agree, by any means. How would a lay person without training be able to distinguish,
for example, a stroke related white matter hyper-intensity from an MS lesion? Or even a large MR artifact?
Averaging will reduce variance in prediction, but the individual prediction itself has to be unbiased. In
other words: the layman predictor has to be correct on average. But how would they possibly be in case
they have no idea about how to read these data? Moreover, the authors point out that "studies with
medical students show that working in pairs ameliorates diagnostic ability". Is this because of a better
discussion of the decision? With two subjects it cannot be the power of large numbers that this study
relies on.
Instead of exploring how to fuse layman's decisions, I would recommend the authors to explore how to
fuse decisions of different algorithms, or from neurologists of different training/seniority level, or decisions
based on different sources.
Technical:
 The authors describe a "leave-one patient-out" cross-validation as anExperimental setup and evaluation:
innovation of their study. While this is a good approach, it is not new.
 There are different classes - what is the distribution of those classes for the 84Algorithm and training:
patients? What is in the reports? Numbers? Free text? What features are input to the random forest
algorithm? How many features at all? How did you train the algorithm (parameters "mtry", why 50 trees?)
Without this information it is difficult to assess whether the performance of your random forest is bad (i.e.,
close to layman's predictions) because of an suboptimal training procedure, or because this is a hard
problem indeed.
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 problem indeed.
 (Described in the section "To compare the two sets... of the most consistent agent.") I don'tFusion rule:
understand what you do. How does summing a squared ranking lead to a prediction score? I assume you
are using the normalized (and squared) ranking as a sort of weight? Why do you square the rankings?
What happens when you use other non-linear transformations? Is there any way you illustrate the
distributions so that we can follow your reasoning? How about presenting simple rules like averaging, or
majority voting at least as a baseline we can compare against?
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
No
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
No
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 21 March 2018Referee Report
doi:10.5256/f1000research.14226.r31369
 Roger Tam
Department of Radiology and MS/MRI Research Group, University of British Columbia, Vancouver, BC,
Canada
This is an interesting and clearly written article on using a machine learning method (random forests) and
medical students to form "hybrid" predictions of disease progression in MS, specifically the conversion
from RRMS to SPMS. The article claims that the results are a proof-of-principle that combining machine
learning and human predictions is better than either approach alone. 
The main strengths of the article are its clear writing, the reproducbility of the experiments, the clinical
importance of the application, and topical nature of the subject, as machine learning for clinical prediction
is such a hot topic that integration with the clinical workflow is a critical area of study.
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 The main limitations of the article are that only clinical parameters were used to perform the predictions,
and the longitudinal nature of the data was not used to its full benefit. To realize the potential of machine
learning for MS prediction, imaging parameters should be included (there is good literature on MS
prediction using imaging), and examining changes over time is important for both machine (eg, using
recurrent networks) and human raters (examining clinical changes over multiple time points). The article
places some importance on having the computer and humans using the same set of input parameters, but
I do not feel that this is warranted; the data should be selected to be most appropriate for each approach.
Given the above limitations, it is difficult to generalize the findings to say that hybrid predictions are better
than either machine learning or humans. This could be true, and the article provides some support for
that, but more work needs to be done to provide strong evidence.
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 26 February 2018Referee Report
doi:10.5256/f1000research.14226.r30349
 Bruno Bonetti
USD Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
The manuscript is interesting and intriguing, since it opens new possibilities in MS prognosis combining
human expertise and "artificial intelligence". I do not understand why medical students have been chosen
instead of (young) neurologists who may have additional skills in the specific task. Apart from this aspect,
the manuscript is well written and easy to follow. Deserves publication.
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 Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
I cannot comment. A qualified statistician is required.
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
Author Response 01 Mar 2018
, Sapienza University of Rome, ItalyFrancesca Grassi
Thank you very much for reviewing our paper.
In this proof-of-concept study, we chose to work with medical students instead of neurologists
because we wanted to test if even a group of relatively uneducated people can enhance the
predictive ability of machine learning algorithms, which is now well established.
We agree with you that the next step is to obtain predictions by neurologists and other medical
doctors, and in fact we set up the platform DiagnoShare (http://www.phys.uniroma1.it/diagnoshare
) to extend the study.
Hopefully, we can soon extend this work with a final study 
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